Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin McDonnell

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neurology|May 4, 2018
Free health care, great data, and new clues on multiple sclerosisGary M Franklin, Gavin McDonnell
Neurology|July 24, 2013
Re: Tumefactive multiple sclerosis lesions under fingolimod treatmentMichael O Kinney, Gavin McDonnell
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|November 25, 2003
A review of the management of Guillain-Barré syndrome in a regional neurological rehabilitation unitAine Carroll, Gavin McDonnell, Mike Barnes
Neurology|January 15, 2014
Teaching NeuroImages: facial diplegia due to neuroborreliosisJamie Campbell, John McNamee, Peter Flynn, et al.
Clinical Medicine (London, England)|May 31, 2015
Helping patients and the emergency department: enhanced patient care and reduced hospital admission rates with a pilot rapid access neurology clinic (RANC)Thomas Peukert, Stella Hughes, Richard Wilson, et al.
Multiple Sclerosis and Related Disorders|December 1, 2018
Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview studyElaine Cameron, David Rog, Gavin McDonnell, et al.
Journal of Neuroimmunology|December 19, 2006
The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosisStephen Cunningham, Catherine O'Doherty, Chris Patterson, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genesStephen Cunningham, Colin Graham, Michael Hutchinson, et al.
Journal of Neuroimmunology|May 26, 2007
CTLA4 gene polymorphisms and multiple sclerosis in Northern IrelandShirley Heggarty, Vijayaprakash Suppiah, Jonathan Silversides, et al.
Journal of Neuroimmunology|October 25, 2003
A genome wide scan for association with multiple sclerosis in a N. Irish case control populationShirley Heggarty, Stephen Sawcer, Stanley Hawkins, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neurology|May 4, 2018
Free health care, great data, and new clues on multiple sclerosisGary M Franklin, Gavin McDonnell
Neurology|July 24, 2013
Re: Tumefactive multiple sclerosis lesions under fingolimod treatmentMichael O Kinney, Gavin McDonnell
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|November 25, 2003
A review of the management of Guillain-Barré syndrome in a regional neurological rehabilitation unitAine Carroll, Gavin McDonnell, Mike Barnes
Neurology|January 15, 2014
Teaching NeuroImages: facial diplegia due to neuroborreliosisJamie Campbell, John McNamee, Peter Flynn, et al.
Clinical Medicine (London, England)|May 31, 2015
Helping patients and the emergency department: enhanced patient care and reduced hospital admission rates with a pilot rapid access neurology clinic (RANC)Thomas Peukert, Stella Hughes, Richard Wilson, et al.
Multiple Sclerosis and Related Disorders|December 1, 2018
Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview studyElaine Cameron, David Rog, Gavin McDonnell, et al.
Journal of Neuroimmunology|December 19, 2006
The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosisStephen Cunningham, Catherine O'Doherty, Chris Patterson, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genesStephen Cunningham, Colin Graham, Michael Hutchinson, et al.
Journal of Neuroimmunology|May 26, 2007
CTLA4 gene polymorphisms and multiple sclerosis in Northern IrelandShirley Heggarty, Vijayaprakash Suppiah, Jonathan Silversides, et al.
Journal of Neuroimmunology|October 25, 2003
A genome wide scan for association with multiple sclerosis in a N. Irish case control populationShirley Heggarty, Stephen Sawcer, Stanley Hawkins, et al.
Pageof 3